History of Obstructive Pyelonephritis Treated Without Drainage as a Risk Factor for Febrile Urinary Tract Infection After Ureteroscopic Lithotripsy: A Retrospective Study From Three Institutions

既往有梗阻性肾盂肾炎病史且未行引流治疗是输尿管镜碎石术后发生发热性尿路感染的危险因素:来自三家机构的回顾性研究

阅读:1

Abstract

PURPOSE: Preoperative obstructive pyelonephritis (OP) increases the risk of febrile urinary tract infection (fUTI) after ureteroscopic lithotripsy (URSL). This study aimed to investigate the effect of a history of OP treated without drainage on post‑URSL fUTI. METHODS: We retrospectively reviewed the medical records of 343 consecutive patients who underwent URSL at three institutions between January 2021 and April 2024. Risk factors for post‑URSL fUTI were analyzed, and frequencies were compared among patients with a history of OP treated without drainage, those with a history of OP treated with ureteral stent (US) placement, and those without a history of OP. RESULTS: Of the 343 patients, 29 (8.5%) developed post‑URSL fUTI. Multivariate logistic regression analysis revealed that a history of OP (p < 0.001) and preoperative positive urine culture (p = 0.043) were independent risk factors for post‑URSL fUTI. The incidence of post‑URSL fUTI was significantly higher in patients with OP treated with drainage than in those without a history of OP (p < 0.001). Moreover, the incidence of post‑URSL fUTI in patients with OP treated without drainage was significantly higher than that in patients treated with US placement (p = 0.030). CONCLUSION: In this study, the incidence of post‑URSL fUTI in patients with OP treated without drainage was significantly higher than that in those treated with US placement. A history of OP treated without drainage might represent the highest risk factor for post‑URSL fUTI. Therefore, calculous pyelonephritis probably should be managed with drainage to mitigate this risk.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。